A new study published in Psychoneuroendocrinologysheds light on the complex relationship between postnatal depression and ...

When oxytocin is inhaled via a nasal spray, it increases breast milk oxytocin levels, but it has less of an effect in new ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment cheaper for thousands of Australians.

Spravato (esketamine) is a prescription drug that’s approved to treat certain forms of depression. Esketamine comes as a nasal spray that you inhale. Specifically, Spravato is approved by the ...

This is when a patient has tried multiple forms of treatment for major depression—usually at ... The drug is provided as a single-use nasal spray. This application means it's absorbed directly ...

It is the first new medicine to treat depression funded by the Australian government in over 30 years. Image: iStock Esketamine nasal spray will soon be subsidised under the Pharmaceutical ...

Nevada Mental Health, one of the state’s largest psychiatric practices, just started offering SPRAVATO®, a nasal mist ...

You’ve taken the pills. You’ve journaled. You’ve done therapy, yoga, and even tried giving up caffeine and doom-scrolling ...

Postnatal depression occurs in approximately 20% ... All mothers were invited to use a nasal spray prior to breastfeeding which contained either the oxytocin hormone or a placebo.

The drug is provided as a single-use nasal spray . This application means ... need to have been diagnosed with treatment-resistant depression . In practice, this means they will have ...

This is when a patient has tried multiple forms of treatment for major depression – usually at ... The drug is provided as a single-use nasal spray. This application means it’s absorbed ...